Sartorius completes acquisition of MatTek Kumar Jeetendra | July 2, 2025 The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO Group AB, as announced in April. The acquisition was completed on July 1, 2025, following the receipt of the required regulatory approval and the fulfillment of other customary closing conditions. With the integration of the …
Jodi Barrientos on Leading Synthetic Biology’s Next Wave Kumar Jeetendra | October 6, 2025 Microbioz India recently hosted a podcast in which Jodi Barrientos, CEO of Ribbon Bio, very eloquently described her career path, her thoughts on the future of synthetic bio, and the change(s) she hopes to implement in our industry. Jodi Barrientos spent 17 years in the commercial sector, exceeding the expectations of some of the world’s …
2025 in Review: A Defining Year for Pharma, Laboratory & Analytical Industry Kumar Jeetendra | January 6, 2026 By the end of 2025, the pharma, laboratory, and analytical sectors will have undergone an unprecedented overhaul. These industries overcame the pandemic bounce-back and are now completely transformed. Digital tools, regulatory oversight, analytical efficiency, and manufacturing breakthroughs have all advanced these markets.For scientists, manufacturers, solution providers, and leaders in these sectors, 2025 was about operational …
Unlocking Innovation: Antibody Applications in Modern Research Kumar Jeetendra | April 20, 2026 Innovation in life sciences has been fueled by antibodies. Antibodies were tied to the body’s immune response, but are now used in groundbreaking studies in modern investigations. They are used in diagnostics, therapeutics, and other studies. Unlocking Innovation: Antibody Applications in Modern Life Sciences Antibodies have a defined function in science. Antibodies are immune proteins …
Sequence Detection Systems: Driving Precision in Modern Genomics Kumar Jeetendra | April 22, 2026 Today, we live in a world of advanced biotechnology and precise medicine, no sequencing detection tools are more vital in unlocking the mysteries of our world. They are changing the science of how we identify, study, and treat biological problems and help identify genetic mutations and monitor infection. There are no limits to the advancing …
Scientific Excellence 2026: Advancing Laboratories Beyond Limits Kumar Jeetendra | June 2, 2026 A new epoch is upon the global scientific community. The new laboratory model reaches beyond the isolation of research activities. By 2026, the pharmaceutical, biotech, healthcare, diagnostics, analytical, environmental, and academic laboratories will all be connected through intelligent ecosystems in digital, automated, and sustainable formats. Each of these new models will uphold the highest standards …
Aragen to Manufacture Renaissance Pharma’s Fast-Track mAb Kumar Jeetendra | June 3, 2026 Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has successfully tech-transferred and manufactured the first commercial-scale GMP batches of Renaissance Pharma’s lead candidate, Daretabart – a humanized monoclonal antibody targeting GD2 for high-risk neuroblastoma – in just 9 months. The anti-GD2 monoclonal antibody received Fast Track Designation from the FDA in April 2026 for …
Innovation in Fluidics: A Conversation with Fritiof Pontén, PhD Kumar Jeetendra | July 9, 2026 The life sciences sector’s rapid metamorphosis is obvious, stemming from innovations in the automation of labs, fluidics, digitalization, and sustainability. One individual leading these changes is Dr. Fritiof Pontén, CEO of Biotech Fluidics. His career has taken him from synthetic organic chemistry to global leadership in innovation, granting Dr. Pontén a thorough understanding of the …
Science in Motion:The Technologies Shaping Tomorrow’s Pharmaceutical Industry Kumar Jeetendra | July 9, 2026 The pharmaceutical sector is experiencing revolutionary changes for the first time in decades. Drug discovery, development, manufacturing, and delivery to patients in all corners of the globe is being altered due to the rapid pace of technologies, enhanced delivery and requests in healthcare, and the development of precision medicine. We are approaching 2026 and the …
